Home › Sakit ni Alzheimer › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Philadelphia, PA
Isang pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Nagre-recruitPhase 2
- Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting · 12 mi ang layo
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Nagre-recruitPhase 2
- Pennsylvania Hospital, Philadelphia
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Nagre-recruitPhase 3
- Flourish Research ? Philadelphia, Plymouth Meeting · 12 mi ang layo
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- Perelman Center for Advance Medicine, Philadelphia
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Nagre-recruitPhase 3
- Keystone Clinical Studies, Plymouth Meeting · 12 mi ang layo
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Nagre-recruit
- Hospital of the University of Pennsylvania, Philadelphia
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
Nagre-recruitObservasyonal na pag-aaral
- University of Pennsylvania, Philadelphia
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Nagre-recruitPhase 2
- Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
Biofluid Research on Age-Related or Inherited Neurodegeneration
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of Pennsylvania, Philadelphia
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Nagre-recruitPhase 2
- Flourish Research ( Site 1048), Plymouth Meeting · 12 mi ang layo
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Nagre-recruit
- Penn Medicine, Philadelphia
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Nagre-recruitPhase 3
- Penn Presbyterian Medical Center, Philadelphia
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Nagre-recruitPhase 2
- Abington Neurological Associates Ltd, Willow Grove · 13 mi ang layo
UPenn Observational Research Repository on Neurodegenerative Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of Pennsylvania, Philadelphia
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
Nagre-recruitMaagang Phase 1
- University of Pennsylvania, Philadelphia
Pag-aaral para sa Sakit ni Alzheimer sa ibang lungsod
- Boston, MA26 pag-aaral
- Orlando, FL25 pag-aaral
- St. Louis, MO22 pag-aaral
- New York City, NY21 pag-aaral
- Miami, FL20 pag-aaral
- Tampa, FL17 pag-aaral
- Atlanta, GA16 pag-aaral
- The Villages, FL15 pag-aaral
- Phoenix, AZ15 pag-aaral
- Indianapolis, IN14 pag-aaral
- Los Angeles, CA14 pag-aaral
- West Palm Beach, FL13 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.